Oncology Breast Cancer Screening and Staging
36 flashcards covering Oncology Breast Cancer Screening and Staging for the HEALTHCARE-CE Physician CME section.
Oncology breast cancer screening and staging encompasses the systematic approach to early detection and classification of breast cancer, guided primarily by the American Cancer Society (ACS) and the National Comprehensive Cancer Network (NCCN) guidelines. These guidelines provide evidence-based recommendations on screening methods, frequency, and the staging process, which is crucial for determining treatment options and prognoses.
In practice exams and competency assessments, questions on this topic often focus on the appropriate screening techniques, age recommendations, and staging criteria. A common trap is the confusion between different staging systems, such as the AJCC (American Joint Committee on Cancer) and FIGO (International Federation of Gynecology and Obstetrics), which can lead to incorrect answers. Additionally, questions may include scenarios requiring the application of guidelines to specific patient cases, testing both knowledge and clinical reasoning.
One concrete tip clinicians often overlook is the importance of individualized screening plans based on patient risk factors, which can significantly influence early detection outcomes.
Terms (36)
- 01
What is the recommended age to begin screening for breast cancer according to USPSTF guidelines?
Women should begin screening for breast cancer at age 50 and continue biennially until age 74. For women aged 40-49, the decision to start screening should be an individual one (USPSTF Recommendations, current edition).
- 02
How often should women aged 50-74 have a mammogram per USPSTF recommendations?
Women aged 50-74 should have a mammogram every two years (biennially) according to USPSTF guidelines (USPSTF Recommendations, current edition).
- 03
What is the primary screening method recommended for breast cancer?
The primary screening method recommended for breast cancer is mammography (USPSTF Recommendations, current edition).
- 04
Under USPSTF guidelines, what is the recommendation for breast self-examination?
The USPSTF does not recommend teaching breast self-examination as a screening method for breast cancer due to insufficient evidence of benefit (USPSTF Recommendations, current edition).
- 05
What is the recommended screening approach for women at high risk for breast cancer?
Women at high risk for breast cancer should be screened with both mammography and MRI annually (USPSTF Recommendations, current edition).
- 06
What is the significance of the Breast Imaging Reporting and Data System (BI-RADS) in mammography?
BI-RADS provides a standardized system for reporting mammography findings, which helps in assessing breast cancer risk and guiding further management (American College of Radiology).
- 07
When should clinical breast exams be performed according to the ACOG guidelines?
Clinical breast exams should be performed every 1-3 years for women aged 20-39 and annually for women 40 and older (ACOG Practice Bulletin).
- 08
What staging system is commonly used for breast cancer?
The AJCC (American Joint Committee on Cancer) TNM staging system is commonly used for breast cancer staging, which assesses tumor size (T), lymph node involvement (N), and metastasis (M) (AJCC Cancer Staging Manual).
- 09
What is the purpose of staging in breast cancer management?
Staging is used to determine the extent of cancer spread, which guides treatment decisions and helps predict prognosis (AJCC Cancer Staging Manual).
- 10
What does the 'T' in the TNM staging system represent?
The 'T' in the TNM staging system represents the size and extent of the primary tumor (AJCC Cancer Staging Manual).
- 11
What does the 'N' in the TNM staging system indicate?
The 'N' in the TNM staging system indicates the presence and extent of regional lymph node involvement (AJCC Cancer Staging Manual).
- 12
What does the 'M' in the TNM staging system signify?
The 'M' in the TNM staging system signifies the presence of distant metastasis (AJCC Cancer Staging Manual).
- 13
How is breast cancer classified as stage IV?
Breast cancer is classified as stage IV when there is evidence of distant metastasis, regardless of the size of the primary tumor or lymph node involvement (AJCC Cancer Staging Manual).
- 14
What is the role of genetic testing in breast cancer screening?
Genetic testing for BRCA1 and BRCA2 mutations is recommended for women with a strong family history of breast cancer to assess their risk (NCCN Guidelines).
- 15
What is the recommended follow-up for women with abnormal mammogram results?
Women with abnormal mammogram results should receive additional imaging or biopsy as indicated to further evaluate the findings (USPSTF Recommendations, current edition).
- 16
What are the benefits of early breast cancer detection?
Early detection of breast cancer through screening can lead to earlier treatment, which is associated with improved survival rates (USPSTF Recommendations, current edition).
- 17
What is the recommended interval for breast cancer screening in women aged 40-49?
For women aged 40-49, the decision to screen should be individualized based on risk factors, with mammography recommended but not mandated (USPSTF Recommendations, current edition).
- 18
What factors may influence the decision to screen for breast cancer in younger women?
Factors influencing the decision to screen in younger women include family history, genetic predisposition, and personal health history (USPSTF Recommendations, current edition).
- 19
What is the significance of the grade assigned to breast cancer tumors?
The grade of a breast cancer tumor indicates how abnormal the cancer cells look under a microscope and can help predict how quickly the cancer is likely to grow and spread (AJCC Cancer Staging Manual).
- 20
What is the role of imaging in breast cancer staging?
Imaging studies such as ultrasound, MRI, and CT scans are used in breast cancer staging to evaluate the extent of disease and detect metastasis (AJCC Cancer Staging Manual).
- 21
What is the recommended management for women with dense breast tissue?
Women with dense breast tissue may benefit from supplemental screening with ultrasound or MRI in addition to mammography (USPSTF Recommendations, current edition).
- 22
How does the presence of hormone receptors affect breast cancer treatment?
The presence of hormone receptors (estrogen and progesterone) on breast cancer cells can guide treatment options, including hormone therapy (NCCN Guidelines).
- 23
What is the significance of HER2 status in breast cancer?
HER2 status helps determine the aggressiveness of the cancer and guides targeted therapy options (NCCN Guidelines).
- 24
What is the recommended action for women with a family history of breast cancer?
Women with a family history of breast cancer should discuss genetic counseling and consider early screening options with their healthcare provider (NCCN Guidelines).
- 25
What is the role of the oncotype DX test in breast cancer management?
The Oncotype DX test assesses the likelihood of breast cancer recurrence and can help guide treatment decisions, particularly regarding chemotherapy (NCCN Guidelines).
- 26
What is the importance of patient education in breast cancer screening?
Patient education is crucial to ensure women understand the benefits and limitations of screening and to encourage participation in regular mammography (USPSTF Recommendations, current edition).
- 27
What are the potential harms associated with breast cancer screening?
Potential harms of breast cancer screening include false positives, unnecessary biopsies, and overdiagnosis (USPSTF Recommendations, current edition).
- 28
What is the role of multidisciplinary teams in breast cancer care?
Multidisciplinary teams are essential in breast cancer care to provide comprehensive treatment planning and management involving various specialties (NCCN Guidelines).
- 29
What follow-up care is recommended after breast cancer treatment?
Follow-up care after breast cancer treatment typically includes regular physical exams, imaging as needed, and monitoring for recurrence (NCCN Guidelines).
- 30
What lifestyle modifications are recommended for breast cancer survivors?
Breast cancer survivors are encouraged to adopt a healthy lifestyle, including regular exercise, a balanced diet, and weight management to reduce recurrence risk (NCCN Guidelines).
- 31
What is the recommended approach for breast cancer screening in men?
Men at high risk for breast cancer, such as those with BRCA mutations, should discuss screening options with their healthcare provider, although routine screening is not standard (NCCN Guidelines).
- 32
What is the significance of axillary lymph node involvement in breast cancer staging?
Axillary lymph node involvement is a critical factor in staging breast cancer, influencing prognosis and treatment options (AJCC Cancer Staging Manual).
- 33
What is the recommended imaging modality for evaluating suspected breast cancer recurrence?
MRI is often the preferred imaging modality for evaluating suspected breast cancer recurrence due to its sensitivity (NCCN Guidelines).
- 34
What is the role of palliative care in advanced breast cancer?
Palliative care plays a vital role in managing symptoms and improving quality of life for patients with advanced breast cancer (NCCN Guidelines).
- 35
What is the recommended frequency of follow-up visits for breast cancer survivors?
Breast cancer survivors should have follow-up visits every 3-6 months for the first few years, then annually thereafter, depending on individual risk factors (NCCN Guidelines).
- 36
What is the importance of psychosocial support in breast cancer care?
Psychosocial support is important in breast cancer care to address emotional, social, and psychological needs of patients throughout their treatment journey (NCCN Guidelines).